Bempedoic acid (United Kingdom) — Patient-Friendly Medicine Information
Bempedoic acid is a prescription medicine used to help lower low-density lipoprotein cholesterol (LDL-C), often referred to as “bad cholesterol.” It is used alongside other cholesterol-lowering approaches, such as a healthy diet and—where appropriate—other medicines.
This guide explains how bempedoic acid works, how it is used, what to expect, and key safety information. It is written for patients and carers in the United Kingdom.
Quick product overview
| Topic | Information |
|---|---|
| Generic name | Bempedoic acid |
| What it’s for | Helps reduce LDL-C and, in many people, other cholesterol measures |
| How it works | Inhibits cholesterol production in the liver |
| Typical form | Oral tablet (strengths may vary by brand/product) |
| Common dosing frequency | Once daily (exact regimen depends on your plan) |
| Key safety points | May increase uric acid (gout risk), can affect muscle symptoms in some patients, and can alter kidney/liver blood tests |
What is bempedoic acid?
Bempedoic acid is a cholesterol-lowering medicine that targets a step in the body’s cholesterol production pathway. It is designed to work primarily in the liver, which can help lower LDL cholesterol levels while aiming to reduce certain side effects seen with some other lipid-lowering medicines.
It is commonly considered for people with cardiovascular risk or established cardiovascular disease who need additional LDL-C lowering despite lifestyle changes and/or other therapies.
Mechanism of action (how it works)
Bempedoic acid helps reduce cholesterol by inhibiting an enzyme called ATP-citrate lyase (an upstream regulator in the cholesterol synthesis pathway).
- By blocking cholesterol synthesis, the liver tends to increase LDL receptor activity.
- This results in more LDL being removed from the bloodstream.
- Overall, LDL-C is reduced, which may help lower long-term cardiovascular risk.
Unlike some other cholesterol-lowering medicines, bempedoic acid is not a statin. It may be used when additional LDL lowering is needed, or when there are limitations with other options.
Pharmacokinetics (how the body handles it)
Pharmacokinetics describes what happens to a medicine after you take it: absorption, distribution, metabolism, and elimination.
- Absorption: Bempedoic acid is absorbed from the gut after oral dosing. The active effect involves conversion to an active metabolite.
- Activation: The liver is an important site for conversion to the active form.
- Protein binding: The medicine and/or metabolite bind to blood proteins to some extent.
- Metabolism: It is metabolised largely in the body through pathways that can involve the liver.
- Elimination: The medicine and metabolites are eliminated mainly via the liver/bile and the kidneys to a lesser extent, depending on the compound and route.
- Time to effect: LDL-C lowering is not immediate; cholesterol levels typically begin improving within weeks, with more stable changes over continued use.
Your healthcare team may monitor blood lipids and some safety markers during treatment.
What is it used for in the UK?
In clinical practice in the UK, bempedoic acid is used to help reduce LDL cholesterol in people who are at higher cardiovascular risk and who need further LDL lowering beyond what is achieved with lifestyle measures and/or other lipid-lowering therapies.
Common indication scenarios include:
- Primary prevention in some high-risk groups (depending on individual assessment and treatment eligibility).
- Secondary prevention (people with established cardiovascular disease) where additional LDL lowering is needed.
- Situations where extra LDL reduction is desired alongside other cholesterol-lowering medicines.
Eligibility and the exact “labelled” use may depend on the product licence and local prescribing decisions. If you are unsure whether it is suitable for your situation, ask a healthcare professional.
When and how to take it (timing and dosing)
Bempedoic acid is typically taken once daily. Many patients find it easiest to take it at the same time each day.
Typical timing tips:
- Choose a time you can stick to daily.
- Consistency helps you remember and keeps treatment steady.
- If you miss a dose, follow your prescribed instructions or ask a pharmacist for guidance.
How to take:
- Swallow the tablet whole with water.
- Try not to crush or chew unless your pharmacist advises it is appropriate.
What to expect over time:
- Cholesterol results are usually assessed during follow-up appointments and blood tests.
- Don’t stop or change your dose because you “feel better”—cholesterol targets are based on measurements.
Food interactions
Most cholesterol-lowering medicines have some food considerations, but bempedoic acid is generally used with flexible timing regarding meals. Many people can take it with or without food.
Practical guidance:
- If your medicine label or instructions say “take with food,” follow those directions.
- If no specific instructions are given, take it in the way that best fits your routine (with water), and keep the same approach day to day.
If you have swallowing difficulties or gastrointestinal conditions, discuss options with a pharmacist.
Alcohol and medicine interactions
Alcohol does not have a simple “direct” interaction with bempedoic acid for every person, but drinking alcohol can affect your overall health and may influence liver function, blood lipids, and the risk of side effects.
- Moderation is advisable. If you drink regularly or in large amounts, speak with a clinician.
- Watch for symptoms of liver problems (see “Safety profile” below).
- Gout risk: Alcohol—particularly beer and spirits—can raise uric acid levels in some people, potentially increasing gout flare risk.
For people taking multiple medicines, it’s important to review your full medication list (including over-the-counter products) because some interactions relate to other drugs rather than alcohol alone.
Medicine interactions (important)
Interactions can change how well treatments work or increase side-effect risk. Always tell your pharmacist or prescriber about all medicines you take.
Key interaction considerations may include:
- Cholesterol-lowering regimens: bempedoic acid may be used with other lipid therapies. Your clinician will plan the combination to achieve targets safely.
- Urate/gout-related medicines: If you have a history of gout or raised uric acid, your doctor may adjust monitoring or treatment.
- Medicines that affect liver function: Use caution with substances that may strain the liver, including certain medications and supplements.
- Blood sugar medicines: In some patients, clinicians monitor metabolic markers as part of broader cardiovascular risk management.
The safest approach is to check interactions for your exact brand and dose using information from a pharmacist, especially if you take medicines for kidney disease, gout, blood clots, diabetes, or immune conditions.
Dosing guidance (typical regimen)
Many patients take once daily bempedoic acid.
General principles:
- Take it at the same time each day.
- Do not double up to make up for a missed dose unless instructed.
- If you have kidney or liver problems, dosing and monitoring may be adjusted.
Your prescribed dose and any additional instructions (such as monitoring schedule) are based on your health history and laboratory results.
Safety profile (what to know before and during treatment)
Common side effects
Not everyone gets side effects, but possible reactions can include:
- Raised uric acid (which may trigger or worsen gout in susceptible people)
- Muscle symptoms in some patients (for example, pain or weakness), although the pattern may differ from statin-associated muscle effects
- Changes in liver blood test results in some people
- Generalised effects such as tiredness or headache (reported in some patients)
Serious or urgent warning signs
Seek medical advice promptly if you experience any of the following:
- Signs of gout flare: sudden joint pain/swelling, often in the big toe, ankle, or knee.
- Severe muscle symptoms: unusual muscle pain, tenderness, weakness, especially if accompanied by dark urine.
- Signs of liver problems: yellowing of the skin/eyes (jaundice), dark urine, severe fatigue, upper right abdominal pain.
- Allergic reaction signs: swelling of the face/lips, rash, or difficulty breathing.
Special populations
- Kidney problems: monitoring may be considered depending on severity and other risk factors.
- Liver problems: clinicians may monitor liver tests and assess risk.
- History of gout or raised uric acid: extra care is often needed. Your clinician may recommend preventive strategies or medicines.
- Older adults: risk may depend on comorbidities and other medicines.
Practical use tips for everyday life
- Keep a medication routine: use a daily reminder on your phone or a pill organiser.
- Know your baseline tests: ask what your latest cholesterol, liver enzymes, and uric acid levels are.
- Report muscle symptoms early: don’t “wait it out” if you notice severe or persistent muscle pain or weakness.
- Hydration and gout prevention: drink fluids sensibly and follow any gout prevention plan your clinician provides.
- Don’t change your cholesterol plan without review: diet, exercise, and other medicines form part of the overall strategy.
- Maintain lifestyle measures: bempedoic acid works best alongside heart-healthy changes.
Typical expectations and monitoring
Your healthcare provider may schedule blood tests to track:
- Lipid levels (to check LDL-C response)
- Uric acid (especially if you have gout risk)
- Liver function tests (based on clinical judgement)
- Other markers as part of your broader cardiovascular risk management plan
If you miss appointments, cholesterol may not be adjusted effectively—so it’s helpful to keep follow-ups.
Alternative options (if bempedoic acid isn’t suitable)
Depending on your cholesterol level, cardiovascular risk, medical history, and side-effect profile, clinicians may consider other cholesterol-lowering medicines or strategies. Common alternatives include:
Cholesterol-lowering medicines
- Statins (first-line for many people with high cardiovascular risk)
- Ezetimibe (reduces cholesterol absorption in the gut)
- PCSK9 inhibitors (injectable medicines that reduce LDL-C)
- Bile acid sequestrants (for selected patients)
- Others may be considered based on individual needs and specialist guidance
Lifestyle and supportive measures
- Heart-healthy diet (for example, reducing saturated fats and increasing fibre)
- Regular physical activity
- Weight management where appropriate
- Stopping smoking and limiting alcohol
Your clinician can explain which option best fits your situation and goals.
Recent guidance and clinical context in the UK
Cholesterol management in the UK is guided by national and specialist recommendations and by evidence from clinical trials. In general, modern guidance emphasises:
- Risk-based treatment (treat people at higher cardiovascular risk more intensively)
- Achieving LDL-C targets and reassessing response
- Shared decision-making (balancing benefits, side effects, and patient preferences)
- Combination therapy when a single medicine does not achieve the needed LDL-C reduction
The role of bempedoic acid has been discussed as an additional option for LDL-C lowering in selected patients. Your care team will follow up-to-date recommendations available through NHS and professional pathways.
Delivery and availability in the UK
Bempedoic acid availability may vary by product brand and strength. Online pharmacies in the UK typically offer:
- Home delivery (courier services, generally tracked)
- Packaging designed for safe transport
- Delivery updates by email or text
Delivery times depend on stock location, order cut-off times, and postal/courier schedules. If the product is not immediately available, some pharmacies can obtain it through distribution channels—your provider can confirm lead times.
Storage: Follow the instructions on the outer carton. Keep out of the sight and reach of children and protect from conditions described on the label (commonly away from excessive heat and moisture).
Market and legal context (United Kingdom)
In the UK, medicines must be authorised and supplied in accordance with relevant regulatory requirements. Availability through legitimate pharmacy channels supports:
- Quality and safety assurance (authorised products)
- Proper labelling (dose, warnings, storage conditions)
- Pharmacist advice on appropriate use, interactions, and side effects
If you are buying medication online, ensure the pharmacy is properly registered and provides clear information about product authenticity, storage, and delivery terms.
FAQ — Frequently asked questions
1) How quickly will my cholesterol improve?
LDL-C reductions usually become noticeable within the first few weeks, but full effect is assessed over time. Your clinician typically monitors with blood tests after starting or adjusting therapy.
2) Can I take bempedoic acid with food?
Many patients can take it with or without food. Follow the instructions given with your medicine label. If you are unsure, ask your pharmacist.
3) Is bempedoic acid a statin?
No. Bempedoic acid works by inhibiting a different enzyme in cholesterol synthesis. It is used as part of a broader cholesterol-lowering strategy.
4) Will it cause muscle pain?
Muscle-related symptoms can occur with lipid-lowering therapies. If you develop new or severe muscle pain, weakness, or dark urine, seek medical advice promptly.
5) What if I have gout?
Bempedoic acid can raise uric acid levels in some people, which may increase gout flare risk. Your clinician may monitor uric acid and recommend prevention strategies if you have a history of gout.
6) What should I do if I miss a dose?
Follow the guidance provided with your medicine or ask a pharmacist for advice. In general, do not take extra doses to “catch up” unless instructed.
7) Are there alcohol restrictions?
There are no universal strict alcohol bans, but moderation is recommended. Alcohol can affect liver health and may increase gout risk in some people. If you have concerns, ask a healthcare professional.
8) Can I take it alongside my other cholesterol medicines?
Often, yes—bempedoic acid may be used alongside other lipid-lowering therapies depending on your needs. Your pharmacist can check combinations for safety and interaction risk.
9) What monitoring will I need?
You may need blood tests to check cholesterol response and safety markers such as uric acid and liver function, depending on your risk factors and clinical plan.
10) When should I stop and get urgent help?
Stop taking the medicine only if advised by a clinician. Get urgent help for severe allergic reactions, severe muscle symptoms (especially with dark urine), or signs of liver problems such as jaundice.
Important final reminder
This information is designed to help you understand bempedoic acid. It does not replace advice from a healthcare professional. If you have questions about suitability, side effects, or how to take your medicine, contact a pharmacist or prescriber for tailored guidance.

